These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3490657)
21. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. Reincke M; Allolio B; Würth G; Winkelmann W J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081 [TBL] [Abstract][Full Text] [Related]
22. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions. Davidson D; Stalcup SA J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971 [TBL] [Abstract][Full Text] [Related]
23. Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons. Borsody MK; Weiss JM Brain Res; 1996 Jun; 724(2):149-68. PubMed ID: 8828564 [TBL] [Abstract][Full Text] [Related]
24. [Effect of prostaglandin Bl on systemic and regional hemodynamics]. Ismailov ShI; Flerov EV Biull Eksp Biol Med; 1977 Feb; 83(2):131-3. PubMed ID: 851612 [TBL] [Abstract][Full Text] [Related]
25. Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey. Olster DH; Ferin M J Clin Endocrinol Metab; 1987 Aug; 65(2):262-7. PubMed ID: 3110201 [TBL] [Abstract][Full Text] [Related]
26. Haemodynamic effects of single-dose felodipine in normal man. Agner E; Rehling M; Trap-Jensen J Drugs; 1985; 29 Suppl 2():36-40. PubMed ID: 3987549 [TBL] [Abstract][Full Text] [Related]
27. Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action. Helke CJ; Phillips ET; O'Neill JT J Pharmacol Exp Ther; 1987 Jul; 242(1):131-6. PubMed ID: 2441024 [TBL] [Abstract][Full Text] [Related]
28. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin. Tizabi Y; Aguilera G Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816 [TBL] [Abstract][Full Text] [Related]
29. Effects of endothelin-1 and sarafotoxin S6b on regional hemodynamics in the conscious dog. Leadley RJ; Zhu JL; Goetz KL Am J Physiol; 1991 Jun; 260(6 Pt 2):R1210-7. PubMed ID: 2058748 [TBL] [Abstract][Full Text] [Related]
30. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP. Watanobe H; Tamura T J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular effects of protamine sulfate in man. Shapira N; Schaff HV; Piehler JM; White RD; Still JC; Pluth JR J Thorac Cardiovasc Surg; 1982 Oct; 84(4):505-14. PubMed ID: 7121041 [TBL] [Abstract][Full Text] [Related]
32. Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone. Allolio B; Schulte HM; Deuss U; Kallabis D; Hamel E; Winkelman W Acta Endocrinol (Copenh); 1987 Apr; 114(4):509-14. PubMed ID: 3033966 [TBL] [Abstract][Full Text] [Related]
33. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications. Kling MA; Gardner DL; Calogero AE; Coppola R; Trettau J; Kellner CH; Lefter L; Hart MJ; Cowdry RW; Post RM J Pharmacol Exp Ther; 1994 Mar; 268(3):1548-64. PubMed ID: 8138967 [TBL] [Abstract][Full Text] [Related]
34. Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat. Sirén AL; Powell E; Feuerstein G Am J Physiol; 1986 Jun; 250(6 Pt 2):H1093-101. PubMed ID: 3087219 [TBL] [Abstract][Full Text] [Related]
35. Hypothalamic opioid mu-receptors regulate discrete hemodynamic functions in the conscious rat. Sirén AL; Feuerstein G Neuropharmacology; 1991 Feb; 30(2):143-52. PubMed ID: 1851544 [TBL] [Abstract][Full Text] [Related]
36. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. Schlaghecke R; Kornely E; Santen RT; Ridderskamp P N Engl J Med; 1992 Jan; 326(4):226-30. PubMed ID: 1309389 [TBL] [Abstract][Full Text] [Related]
37. Behavioral and physiologic effects of CRH administered to infant primates undergoing maternal separation. Kalin NH; Shelton SE; Barksdale CM Neuropsychopharmacology; 1989 Jun; 2(2):97-104. PubMed ID: 2545222 [TBL] [Abstract][Full Text] [Related]
38. Endocrine and cardiovascular responses to corticotropin-releasing hormone in patients with posttraumatic stress disorder: a role for atrial natriuretic peptide? Kellner M; Yassouridis A; Hübner R; Baker DG; Wiedemann K Neuropsychobiology; 2003; 47(2):102-8. PubMed ID: 12707494 [TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Ishiyama Y; Kitamura K; Ichiki Y; Nakamura S; Kida O; Kangawa K; Eto T Eur J Pharmacol; 1993 Sep; 241(2-3):271-3. PubMed ID: 8243562 [TBL] [Abstract][Full Text] [Related]
40. Long-term hemodynamic actions of atrial natriuretic factor (99-126) in conscious sheep. Parkes DG; Coghlan JP; McDougall JG; Scoggins BA Am J Physiol; 1988 Apr; 254(4 Pt 2):H811-5. PubMed ID: 2965519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]